CAS ID: | 216974-75-3 |
Molecular Formula: | |
Molecular Weight: | g/mol |
Monoisotopic Mass: | g/mol |
Class: | Monoclonal antibody |
Natural Product: | No |
Other Names: | RHUMAB-VEGF | R-435 | 12-IGG1 | RG-435 | BEVACIZUMAB | AVASTIN |
Analysis: | N/A |
Trial Record 1
ClinicalTrial ID | NCT01917877 | Disease | Pulmonary fibrosis |
Phase | Phase 2 | Status | Recruiting |
First Received | August 7, 2013 | Last Verified | February 14, 2018 |
Sponsor | Qingdao Central Hospital |
Trial Record 2
ClinicalTrial ID | NCT01166594 | Disease | Fibrosis |
Phase | Phase 4 | Status | Completed |
First Received | July 21, 2010 | Last Verified | February 19, 2015 |
Sponsor | Sunnybrook Health Sciences Centre |
Trial Record 3
ClinicalTrial ID | NCT00854529 | Disease | Bleb fibrosis |
Phase | Phase 2 | Status | Unknown |
First Received | March 3, 2009 | Last Verified | March 3, 2009 |
Sponsor | Rabin Medical Center |
Trial Record 4
ClinicalTrial ID | NCT02591914 | Disease | Subfoveal fibrosis |
Phase | Phase 1 | Status | Completed |
First Received | October 30, 2015 | Last Verified | September 24, 2018 |
Sponsor | Retinal Consultants of Arizona |
Trial Record 5
ClinicalTrial ID | NCT00815594 | Disease | Scar |
Phase | Phase 4 | Status | Unknown |
First Received | December 30, 2008 | Last Verified | December 30, 2008 |
Sponsor | Capital Medical University |
Trial Record 6
ClinicalTrial ID | NCT03095001 | Disease | Peritoneal fibrosis |
Phase | Phase 2 | Status | Recruiting |
First Received | March 29, 2017 | Last Verified | April 13, 2017 |
Sponsor | Chinese PLA General Hospital |
Trial Record 7
ClinicalTrial ID | NCT01408953 | Disease | Keloid |
Phase | Phase 2 | Status | Terminated |
First Received | August 3, 2011 | Last Verified | October 18, 2016 |
Sponsor | Tirgan, Michael H., M.D. |
Trial Record 8
ClinicalTrial ID | NCT00667277 | Disease | Bone marrow fibrosis |
Phase | Phase 2 | Status | Terminated |
First Received | April 28, 2008 | Last Verified | August 22, 2014 |
Sponsor | Ronald Hoffman |
PubChem: | 47208066 |
ChEMBL: | CHEMBL1201583 |